Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series

Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series

BACKGROUND: Chemotherapy-resistant cancer stem cells (CSC) may lead to tumor recurrence in glioblastoma (GBM). The poor prognosis of this disease emphasizes the critical need for developing a treatment stratification system to improve outcomes through personalized medicine. METHODS: We present a cas...

Full description

Bibliographic Details
Main Authors: Tulika Ranjan, Candace M. Howard, Alexander Yu, Linda Xu, Khaled Aziz, David Jho, Jodi Leonardo, Muhammad A. Hameed, Stephen M. Karlovits, Rodney E. Wegner, Russell Fuhrer, Seth T. Lirette, Krista L. Denning, Jagan Valluri, Pier Paolo Claudio
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S193652331930717X

Internet

http://www.sciencedirect.com/science/article/pii/S193652331930717X

Similar Items